Company: CDT
Filing Date: 2025-05-06
Form Type: 8-K
Source: 0001641172-25-008854
Chunk: 0

Company: CDT Equity Inc.
Filing Date: 2025-05-06
Form: 8-K
Item: Item 5.07
Chunk 0
---
Item
5.07. Submission of Matters to a Vote of Security Holders.

On
May 5, 2025, Conduit Pharmaceuticals Inc. (the “ Company”), convened a special meeting of stockholders (the “ Special
Meeting”). Proxies had been submitted by stockholders representing over one-third of the shares of the Company’s common stock
outstanding and entitled to vote, which constituted a quorum. At the Special Meeting, the Company’s stockholders voted on one proposal,
which is described in more detail in the proxy statement.

The
following is a brief description of the matter voted upon and the results, including the number of votes cast for and against the matter
and the number of abstentions and broker non-votes with respect to the matter. Proxies for the Special Meeting were solicited pursuant
to Section 14(a) of the Securities Exchange Act of 1934, as amended, and there was no solicitation in opposition of management’s
solicitation.

Proposal
No. 1

      Votes        Votes      Abstentions         Broker  
        For      Against                       Non-Votes  
 ──────────────────────────────────────────────────────────
  5,065,868      496,473            1,438              0  

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

  Date:            CONDUIT                                      
  May 6, 2025      PHARMACEUTICALS INC.                         
 ────────────────────────────────────────────────────────────────
                   By:                       /s/                
                   Name:                     Andrew             
                   Title:                    Chief